These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33773222)

  • 1. Synthesis, biological evaluation, and molecular docking study of some new rohitukine analogs as protein tyrosine phosphatase 1B inhibitors.
    Balaramnavar VM; Srivastava R; Varshney S; Kumar S; Rawat AK; Chandasana H; Chhonker YS; Bhatta RS; Srivastava AK; Gaikwad AN; Lakshmi V; Saxena AK
    Bioorg Chem; 2021 May; 110():104829. PubMed ID: 33773222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambient ionization mass spectrometry imaging of rohitukine, a chromone anti-cancer alkaloid, during seed development in Dysoxylum binectariferum Hook.f (Meliaceae).
    Mohana Kumara P; Srimany A; Ravikanth G; Uma Shaanker R; Pradeep T
    Phytochemistry; 2015 Aug; 116():104-110. PubMed ID: 25799183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chromatography-free isolation of rohitukine from leaves of Dysoxylum binectariferum: Evaluation for in vitro cytotoxicity, Cdk inhibition and physicochemical properties.
    Kumar V; Guru SK; Jain SK; Joshi P; Gandhi SG; Bharate SB; Bhushan S; Bharate SS; Vishwakarma RA
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3457-63. PubMed ID: 27363938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivo.
    Varshney S; Shankar K; Beg M; Balaramnavar VM; Mishra SK; Jagdale P; Srivastava S; Chhonker YS; Lakshmi V; Chaudhari BP; Bhatta RS; Saxena AK; Gaikwad AN
    J Lipid Res; 2014 Jun; 55(6):1019-32. PubMed ID: 24646949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel PTP1B inhibitors by pharmacophore based virtual screening, scaffold hopping and docking.
    Balaramnavar VM; Srivastava R; Rahuja N; Gupta S; Rawat AK; Varshney S; Chandasana H; Chhonker YS; Doharey PK; Kumar S; Gautam S; Srivastava SP; Bhatta RS; Saxena JK; Gaikwad AN; Srivastava AK; Saxena AK
    Eur J Med Chem; 2014 Nov; 87():578-94. PubMed ID: 25299681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrotacumines G-J, chromone alkaloids from Dysoxylum acutangulum with osteoclast differentiation inhibitory activity.
    Morita H; Nugroho AE; Nagakura Y; Hirasawa Y; Yoshida H; Kaneda T; Shirota O; Ismail IS
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2437-9. PubMed ID: 24767841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
    Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of the efficacy of Dysoxylum binectariferum stem bark and its active constituent rohitukine in regulation of dyslipidemia in rats.
    Mishra SK; Tiwari S; Shrivastava S; Sonkar R; Mishra V; Nigam SK; Saxena AK; Bhatia G; Mir SS
    J Nat Med; 2018 Sep; 72(4):837-845. PubMed ID: 24677095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoliquiritigenin impairs insulin signaling and adipocyte differentiation through the inhibition of protein-tyrosine phosphatase 1B oxidation in 3T3-L1 preadipocytes.
    Park SJ; Choe YG; Kim JH; Chang KT; Lee HS; Lee DS
    Food Chem Toxicol; 2016 Jul; 93():5-12. PubMed ID: 27117918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
    Jiang B; Luo J; Guo S; Wang L
    Bioorg Chem; 2021 Mar; 108():104648. PubMed ID: 33493928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance.
    Zhang X; Tian J; Li J; Huang L; Wu S; Liang W; Zhong L; Ye J; Ye F
    Br J Pharmacol; 2016 Jun; 173(12):1939-49. PubMed ID: 26990621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of rohitukine in leaves and seeds of Dysoxylum binectariferum: an alternate renewable resource.
    Mahajan V; Sharma N; Kumar S; Bhardwaj V; Ali A; Khajuria RK; Bedi YS; Vishwakarma RA; Gandhi SG
    Pharm Biol; 2015 Mar; 53(3):446-50. PubMed ID: 25472605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
    Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
    Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
    Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
    Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of rohitukine-enriched fraction of Dysoxylum binectariferum Hook.f. (leaves) as anti-arthritic phytopharmaceutical candidate: Chemical standardization, in-vivo validation, formulation development and oral pharmacokinetics.
    Kumar V; Bharate SS; Bhurta D; Gupta M; Gandhi SG; Singh D; Jaglan S; Kumar A; Vishwakarma RA; Bharate SB
    J Ethnopharmacol; 2020 May; 254():112758. PubMed ID: 32165175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
    Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
    ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase 1B inhibitors isolated from Artemisia roxburghiana.
    Shah MR; Ishtiaq ; Hizbullah SM; Habtemariam S; Zarrelli A; Muhammad A; Collina S; Khan I
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):563-7. PubMed ID: 26118418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
    Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
    Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.
    Chen YT; Tang CL; Ma WP; Gao LX; Wei Y; Zhang W; Li JY; Li J; Nan FJ
    Eur J Med Chem; 2013 Nov; 69():399-412. PubMed ID: 24090912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.